NRC Health Statistics
Total Valuation
NRC Health has a market cap or net worth of $505.71 million. The enterprise value is $604.98 million.
| Market Cap | 505.71M |
| Enterprise Value | 604.98M |
Important Dates
The last earnings date was Tuesday, October 27, 2026, after market close.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Dec 29, 2026 |
Share Statistics
NRC Health has 21.22 million shares outstanding. The number of shares has decreased by -3.58% in one year.
| Current Share Class | 21.22M |
| Shares Outstanding | 21.22M |
| Shares Change (YoY) | -3.58% |
| Shares Change (QoQ) | -0.55% |
| Owned by Insiders (%) | 48.55% |
| Owned by Institutions (%) | 53.57% |
| Float | 10.92M |
Valuation Ratios
The trailing PE ratio is 88.91 and the forward PE ratio is 24.07.
| PE Ratio | 88.91 |
| Forward PE | 24.07 |
| PS Ratio | 3.52 |
| Forward PS | 3.35 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.41 |
| P/OCF Ratio | 21.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.39, with an EV/FCF ratio of 32.79.
| EV / Earnings | 98.64 |
| EV / Sales | 4.21 |
| EV / EBITDA | 19.39 |
| EV / EBIT | 26.66 |
| EV / FCF | 32.79 |
Financial Position
The company has a current ratio of 0.64
| Current Ratio | 0.64 |
| Quick Ratio | 0.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.30 |
| Debt / FCF | 5.58 |
| Interest Coverage | 4.14 |
Financial Efficiency
Return on equity (ROE) is 248.11% and return on invested capital (ROIC) is 14.56%.
| Return on Equity (ROE) | 248.11% |
| Return on Assets (ROA) | 10.32% |
| Return on Invested Capital (ROIC) | 14.56% |
| Return on Capital Employed (ROCE) | 23.31% |
| Weighted Average Cost of Capital (WACC) | 5.19% |
| Revenue Per Employee | $402,768 |
| Profits Per Employee | $17,179 |
| Employee Count | 357 |
| Asset Turnover | 1.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRC Health has paid $4.07 million in taxes.
| Income Tax | 4.07M |
| Effective Tax Rate | 38.73% |
Stock Price Statistics
The stock price has increased by +77.18% in the last 52 weeks. The beta is 0.24, so NRC Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +77.18% |
| 50-Day Moving Average | 21.22 |
| 200-Day Moving Average | 19.17 |
| Relative Strength Index (RSI) | 66.69 |
| Average Volume (20 Days) | 89,024 |
Short Selling Information
The latest short interest is 725,577, so 3.42% of the outstanding shares have been sold short.
| Short Interest | 725,577 |
| Short Previous Month | 685,621 |
| Short % of Shares Out | 3.42% |
| Short % of Float | 6.65% |
| Short Ratio (days to cover) | 6.33 |
Income Statement
In the last 12 months, NRC Health had revenue of $143.79 million and earned $6.13 million in profits. Earnings per share was $0.27.
| Revenue | 143.79M |
| Gross Profit | 87.27M |
| Operating Income | 22.70M |
| Pretax Income | 10.51M |
| Net Income | 6.13M |
| EBITDA | 31.20M |
| EBIT | 22.70M |
| Earnings Per Share (EPS) | $0.27 |
Balance Sheet
The company has $3.63 million in cash and $102.90 million in debt, with a net cash position of -$99.27 million or -$4.68 per share.
| Cash & Cash Equivalents | 3.63M |
| Total Debt | 102.90M |
| Net Cash | -99.27M |
| Net Cash Per Share | -$4.68 |
| Equity (Book Value) | -9.12M |
| Book Value Per Share | -0.43 |
| Working Capital | -15.14M |
Cash Flow
In the last 12 months, operating cash flow was $23.77 million and capital expenditures -$5.32 million, giving a free cash flow of $18.45 million.
| Operating Cash Flow | 23.77M |
| Capital Expenditures | -5.32M |
| Depreciation & Amortization | 8.50M |
| Net Borrowing | 22.74M |
| Free Cash Flow | 18.45M |
| FCF Per Share | $0.87 |
Margins
Gross margin is 60.69%, with operating and profit margins of 15.78% and 4.48%.
| Gross Margin | 60.69% |
| Operating Margin | 15.78% |
| Pretax Margin | 7.31% |
| Profit Margin | 4.48% |
| EBITDA Margin | 21.70% |
| EBIT Margin | 15.78% |
| FCF Margin | 12.83% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 2.69%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 2.69% |
| Dividend Growth (YoY) | 23.08% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 238.78% |
| FCF Payout Ratio | 73.62% |
| Buyback Yield | 3.58% |
| Shareholder Yield | 6.26% |
| Earnings Yield | 1.12% |
| FCF Yield | 3.65% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 6.29% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRC Health has an Altman Z-Score of 2.85 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.85 |
| Piotroski F-Score | 6 |